084650.KQ
LabGenomics Co., Ltd.
KOE · Healthcare · Medical - Specialties · KR
KRW 500.00
−10.55%Year over year
Reported trailing growth
- Revenue
- -11.7%
- EBITDA
- —
- EBIT
- -13.4%
- EPS
- -49.3%
- Free cash flow
- -10.4%
- Operating cash flow
- -14.5%
Forward estimates
Based on analyst estimates
- Revenue
- +1140.7%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -15.2%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -80.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026